VTN and Alzheimer disease: A correlation has been shown between AD PRS and early-life cognition and hippocampal volumes [30], attenuated cerebrovascular function during young adulthood [31], as well as elevated plasma levels of inflammatory biomarkers in AD patients, including complement proteins [32].